The healthcare industry has been slowly adopting new technology solutions to improve efficiency and patient care, but it’s still largely known for paper-based processes, and for having massive amounts of data1. To make matters worse, it’s estimated that 80% of the data in the healthcare industry is unstructured, in the form of discharge summaries, medical images, and clinical notes.2
Even though the industry has started to adopt technology tools to get better insights and
Read More
Healthcare Algorithms | News, Analysis, Insights - HIT Consultant
Realizing the Dream of AI in Clinical Trials—How to Address Key Challenges
The clinical development process is incredibly time consuming and only yields a success rate of about 10%. One way to reduce the time, cost and success of the clinical development process is to introduce artificial intelligence (AI) into clinical trials and implement AI-driven process automation.
The dream of AI in clinical trial execution is for trial functions to run autonomously, like a self-driving car. A self-driving car knows how fast it is going, where it needs to go,
Read More
Glytec and CPS Integrate to Provide Evidence-Based Glycemic Management
What You Should Know:
- Glytec recently announced that it has been selected by CPS Solutions, LLC (CPS), a leading provider of enterprise pharmacy solutions to hospitals and health systems, to serve as an insulin management technology resource for CPS’ more than 2,200 pharmacy professionals across 800-plus healthcare facilities nationwide.
- Through this collaboration, CPS client facilities may contract for Glytec’s eGlycemic Management System® (eGMS) and Glytec’s technical resources to be
Read More
Using AI to Match Patients with Clinical Trials for Proactive Treatment
We are entering a new era of patient treatment options thanks to cutting-edge technologies that are changing the way life science companies approach and execute pharmaceutical research. One of the more significant solutions that support the faster and more efficient development of new pharmaceutical products – such as the COVID-19 vaccine, which was developed faster than any other vaccine in history – is artificial intelligence (AI)-driven data analysis. Thanks to modern life science technology
Read More
Abridge Secures $12.5M to Power AI-Powered Medical Conversations
What You Should Know:
- Abridge, the leader in medical conversation artificial intelligence (AI), today announced an oversubscribed $12.5M Series A-1 led by Wittington Ventures.
- The round also had participation from all existing investors including Union Square Ventures, Bessemer Venture Partners, Pillar Venture Capital, and UPMC Enterprises, and new investors including Turing Award winner Yoshua Bengio, and Whistler Capital.
Automated Solutions to Combat Physician
Read More
Sibel Health Raises $33M for Advanced Wearable Sensors for RPM
What You Should Know:
- Sibel Health has recently closed a $33M Series B financing round, bringing Sibel's total funding to date to more than $50M.
- In addition, Sibel has announced two new executive appointments. Jon Otterstatter, the former CEO and co-founder of Preventice (acquired by Boston Scientific in 2021), will join as chairman of the board. Matthew Banet, Ph.D., a world expert in advanced body-worn sensors and previously the CTO and co-founder of toSense and Sotera, joins as
Read More
Tribun Health, Mindpeak Partner on AI Diagnostic Tool for Breast Cancer for Pathologists
What You Should Know:
- Tribun Health, the European leader in software development for digital pathology, is pleased to announce a strategic partnership with Mindpeak, a global leader for pathology artificial intelligence (AI) software with world-class industry experts in the development of AI algorithms to provide precision and speed in clinical pathology.
- Together, Tribun Health and Mindpeak help pathologists analyze whole-slide-images (WSI) of immunohistochemically (IHC) stained human
Read More
TidalHealth to Deploy AI Co-Pilot to Combat Clinician Burnout
What You Should Know:
- TidalHealth, a health system dedicated to community health and patient-centric care, today announced a new partnership with Regard, a company developing an artificial intelligence (AI) co-pilot for physicians to help diagnose medical conditions, and hip.
- Through the implementation of Regard’s software, physicians within the TidalHealth network are able to automate electronic health record (EHR) chart reviews and enhance patient safety by ensuring all diagnoses are
Read More
NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers
What You Should Know:
- NeuroSense Therapeutics Ltd., a company developing treatments for severe neurodegenerative diseases, and NeuraLight, a company developing objective and sensitive biomarkers for neurological disorders, today announced a collaboration to advance the science of digital biomarkers in the detection and monitoring of neurological diseases including amyotrophic lateral sclerosis (ALS).
- This agreement marks NeuraLight’s first clinical trial and comes on the heels of
Read More
Mayo Clinic, Mercy Sign 10-Year Collaboration to Transform Patient Care
What You Should Know:
- Mayo Clinic and Mercy announced a 10-year collaboration agreement— a first-of-its-kind alliance between two large healthcare systems that will use the most current data science and years of deidentified patient outcomes to find diseases earlier and start patients on paths to better health more quickly.
- With the combination of privacy-protected, cloud-based technology architecture, and the growth of artificial intelligence and machine learning, this aggregated
Read More
